Given the increased consumption of ethanol-containing beverages (47), the doubling of the prevalence of dyslipidemia between 2009 and 2019, and that familial hypercholesterolemia, which is caused by inherited mutations in the LDLR gene, affects 34 million people worldwide, our present study has important clinical implications (48, 49). The gene discussed is LDLR; the disease is metabolic syndrome.